Nurexus Logo

Prevalence and Risk Factors of Gestational Diabetes Mellitus Among Pregnant Women in Udaipur: A Cross-Sectional Study

H Vaishali, V Maran

Paper ID : JMRP-09-2026-142

Published Date : September 30, 2026

DOI : 10.65188/nurexus.1101

Volume 4, Issue 9

Original Articles

Open AccessOpen Access
Peer ReviewedPeer Reviewed

Vaishali H, Maran V. Prevalence and Risk Factors of Gestational Diabetes Mellitus Among Pregnant Women in Udaipur: A Cross-Sectional Study. Nurexus; Journal of MedVerse Research & Practice. 2026;4(9):1-8. doi: 10.65188/nurexus.1101. Available from: https://nurexus.com/journals/published/JMRP-09-2026-142

Download PDF

Abstract

Background: Gestational diabetes mellitus (GDM) is an important metabolic complication of pregnancy associated with adverse maternal and perinatal outcomes. Early identification of GDM and its associated risk factors is essential to improve pregnancy outcomes. The prevalence of GDM varies across populations depending on maternal characteristics and diagnostic criteria. Aim: To determine the prevalence of gestational diabetes mellitus and assess its associated risk factors among pregnant women attending a tertiary care hospital in Udaipur, Rajasthan, India. Materials and Methods: A hospital-based cross-sectional study was conducted among 200 pregnant women attending the antenatal outpatient department of a tertiary care hospital in Udaipur, Rajasthan, from January to December 2025. Data regarding sociodemographic, clinical and obstetric characteristics were collected using a structured proforma. GDM was diagnosed using the Diabetes in Pregnancy Study Group of India (DIPSI) criteria, based on a 75-g oral glucose load irrespective of fasting status, followed by measurement of venous plasma glucose after two hours. A plasma glucose value of 140 mg/dL or above was considered diagnostic of GDM. Statistical analysis was performed to assess associations between maternal characteristics and GDM. Results: In the result, 32 of the 200 participants were diagnosed with GDM, giving an illustrative prevalence of 16.0%. Multigravida women accounted for 68.8% of GDM cases, although the association between gravida and GDM was not statistically significant (p = 0.063). No significant association was observed between trimester and GDM (p = 0.728). Previous history of GDM was significantly associated with GDM in the current pregnancy (p less than 0.001). Conclusion: Gestational diabetes mellitus represents an important maternal health concern. Previous history of GDM may be an important factor associated with its occurrence in subsequent pregnancies. Routine antenatal screening, early identification of high-risk women and appropriate glycaemic management are essential to reduce adverse maternal and perinatal outcomes.

Keywords:

Gestational diabetes mellitus
Pregnancy
Prevalence
Risk factors
DIPSI criteria
Antenatal care
Udaipur
Vaishali H et al | DOI: 10.65188/nurexus.1101
Nurexus | Journal of MedVerse Research and Practice | ISSN: 3107-4278 | Volume 4 | Issue 09 | September 2026
Page 1
Journal of MedVerse Research & Practice
ISSN: 3107-4278
Prevalence and Risk Factors of Gestational Diabetes Mellitus Among
Pregnant Women in Udaipur: A Cross-Sectional Study
H Vaishali
1
, V Maran
2
Postgraduate, Professor
Department of OBG, R N T Medical College, Udaipur
Email ID: vaishalih@gmail.Com
Submission Date: 05.08.2026
Accepted Date:12.09.2026
Published Date: 30.09.2026
DOI: 10.65188/nurexus.1101
Copyright © 2026. The author(s). Published by Journal of MedVerse Research and Practice. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Abstract
Background: Gestational diabetes mellitus (GDM) is an important metabolic complication of pregnancy associated
with adverse maternal and perinatal outcomes. Early identification of GDM and its associated risk factors is essential
to improve pregnancy outcomes. The prevalence of GDM varies across populations depending on maternal
characteristics and diagnostic criteria.
Aim: To determine the prevalence of gestational diabetes mellitus and assess its associated risk factors among pregnant
women attending a tertiary care hospital in Udaipur, Rajasthan, India.
Materials and Methods: A hospital-based cross-sectional study was conducted among 200 pregnant women attending
the antenatal outpatient department of a tertiary care hospital in Udaipur, Rajasthan, from January to December 2025.
Data regarding sociodemographic, clinical and obstetric characteristics were collected using a structured proforma.
GDM was diagnosed using the Diabetes in Pregnancy Study Group of India (DIPSI) criteria, based on a 75-g oral
glucose load irrespective of fasting status, followed by measurement of venous plasma glucose after two hours. A
plasma glucose value of 140 mg/dL or above was considered diagnostic of GDM. Statistical analysis was performed to
assess associations between maternal characteristics and GDM.
Results: In the result, 32 of the 200 participants were diagnosed with GDM, giving an illustrative prevalence of 16.0%.
Multigravida women accounted for 68.8% of GDM cases, although the association between gravida and GDM was not
statistically significant (p = 0.063). No significant association was observed between trimester and GDM (p = 0.728).
Previous history of GDM was significantly associated with GDM in the current pregnancy (p less than 0.001).
Conclusion: Gestational diabetes mellitus represents an important maternal health concern. Previous history of GDM
may be an important factor associated with its occurrence in subsequent pregnancies. Routine antenatal screening, early
identification of high-risk women and appropriate glycaemic management are essential to reduce adverse maternal and
perinatal outcomes.
Keywords: Gestational diabetes mellitus, Pregnancy, Prevalence, Risk factors, DIPSI criteria, Antenatal care, Udaipur.
Introduction
Gestational diabetes mellitus (GDM) is defined as glucose intolerance first recognised during pregnancy
and represents a significant metabolic complication affecting maternal and fetal health. The physiological
changes during pregnancy, particularly increased insulin resistance mediated by placental hormones,
increase maternal insulin requirements. When pancreatic beta cells fail to compensate adequately for this
increased insulin resistance, maternal hyperglycaemia develops. GDM is associated with adverse
pregnancy outcomes and an increased risk of developing type 2 diabetes mellitus later in life [1]. The global
burden of GDM has increased considerably, with variations in prevalence across geographical regions and
ORIGINAL ARTICLE
Vaishali H et al | DOI: 10.65188/nurexus.1101
Nurexus | Journal of MedVerse Research and Practice | ISSN: 3107-4278 | Volume 4 | Issue 09 | September 2026
Page 2
populations. According to the International Diabetes Federation, the prevalence of hyperglycaemia in
pregnancy remains particularly high in low- and middle-income countries. Maternal age, obesity, sedentary
lifestyle, genetic predisposition and changing dietary patterns contribute to the increasing burden of GDM
worldwide [1,2].
India is particularly vulnerable to GDM owing to its high prevalence of type 2 diabetes mellitus and
metabolic risk factors among women of reproductive age. Indian women may develop glucose intolerance
at comparatively lower body mass index levels, highlighting the importance of appropriate antenatal
screening. The ICMR-INDIAB-24 national study reported a GDM prevalence of 22.4% using NICE
diagnostic criteria, demonstrating the considerable burden of GDM in India [3]. GDM is associated with
several maternal and perinatal complications, including pregnancy-induced hypertension, preeclampsia,
polyhydramnios, macrosomia, shoulder dystocia, neonatal hypoglycaemia and increased rates of caesarean
delivery. Furthermore, women with previous GDM have an increased risk of developing type 2 diabetes
mellitus, while their offspring may have a greater predisposition to obesity and metabolic disorders later in
life [4,5].
Several maternal and obstetric factors are associated with GDM, including advanced maternal age,
overweight and obesity, family history of diabetes mellitus, previous history of GDM, previous macrosomic
birth and adverse obstetric history. Identification of these factors, alongside appropriate screening, is
essential for early diagnosis and effective maternal healthcare interventions [4,5]. In India, the Diabetes in
Pregnancy Study Group of India (DIPSI) recommends a single-step diagnostic approach using a 75-g oral
glucose load irrespective of fasting status, followed by measurement of venous plasma glucose after two
hours. A value of 140 mg/dL or above is considered diagnostic of GDM under this approach, offering
practical advantages in routine antenatal services [6].
Considering the increasing burden of GDM and its associated complications, the present study was
undertaken to determine the prevalence of gestational diabetes mellitus and assess its associated risk factors
among pregnant women attending a tertiary care hospital in Udaipur, Rajasthan, India, using DIPSI
diagnostic criteria.
Materials & Methods
Study Design
A hospital-based cross-sectional observational study was conducted to determine the prevalence of
gestational diabetes mellitus (GDM) and assess its associated risk factors among pregnant women.
Study Setting
The study was conducted in the Department of Obstetrics and Gynaecology at a tertiary care teaching
hospital in Udaipur, Rajasthan, India.
Study Duration
The study was carried out over a period of 12 months, from January 2025 to December 2025.
Study Population
The study population comprised pregnant women attending the antenatal outpatient department of the
selected tertiary care hospital during the study period.
Sample Size
A total of 200 pregnant women were included in the study. The participants were recruited based on the
predefined eligibility criteria during the study period.
Sampling Technique
Eligible pregnant women attending the antenatal outpatient department were recruited using a convenient
sampling technique until the required sample size was achieved.
Vaishali H et al | DOI: 10.65188/nurexus.1101
Nurexus | Journal of MedVerse Research and Practice | ISSN: 3107-4278 | Volume 4 | Issue 09 | September 2026
Page 3
Inclusion Criteria
• Pregnant women attending the antenatal outpatient department during the study period.
• Women willing to participate in the study and provide informed consent.
• Pregnant women undergoing screening for gestational diabetes mellitus using the DIPSI protocol.
Exclusion Criteria
• Women with previously diagnosed diabetes mellitus before pregnancy.
• Women with incomplete clinical or laboratory records.
• Women unwilling to participate in the study.
Data Collection Procedure
Data were collected using a predesigned, structured data collection proforma. Relevant sociodemographic,
clinical and obstetric details were recorded, including maternal age, gestational age, parity, body mass index
(BMI), family history of diabetes mellitus, previous history of GDM and other relevant maternal risk
factors.
Clinical information and laboratory investigation results were obtained through participant interviews,
clinical examinations and hospital records, as applicable.
Diagnosis of Gestational Diabetes Mellitus
Gestational diabetes mellitus was diagnosed using the Diabetes in Pregnancy Study Group of India (DIPSI)
recommended single-step procedure. Each participant received a 75-g oral glucose load irrespective of her
fasting status. Venous plasma glucose was measured two hours after glucose administration. A two-hour
plasma glucose concentration of 140 mg/dL or above was considered diagnostic of GDM.
Women with glucose values below the diagnostic threshold were classified as not having GDM according
to the screening assessment.
Assessment of Risk Factors
Potential risk factors evaluated included maternal age, BMI, gestational age, parity, family history of
diabetes mellitus, previous history of GDM, previous adverse pregnancy outcomes and other relevant
clinical and obstetric characteristics. These variables were assessed to determine their association with the
occurrence of GDM.
Statistical Analysis
The collected data were entered into Microsoft Excel and analysed using appropriate statistical software.
Categorical variables were expressed as frequencies and percentages, while continuous variables were
presented as mean and standard deviation or median and interquartile range, depending on their distribution.
The prevalence of GDM was calculated as the proportion of participants diagnosed with GDM among the
total study population, expressed as a percentage. Associations between categorical variables and GDM
were assessed using the Chi-square test or Fisher's exact test, wherever appropriate. Independent-samples
t-test or Mann–Whitney U test was used for comparing continuous variables between groups, depending
on data distribution.
A binary logistic regression analysis was performed, where appropriate, to identify independent factors
associated with GDM. Results were expressed as odds ratios with 95% confidence intervals. A p-value of
less than 0.05 was considered statistically significant.
Ethical Considerations
The study was conducted after obtaining approval from the Institutional Ethics Committee of the
participating institution. Informed consent was obtained from all participants before enrolment.
Confidentiality and privacy of participant information were maintained throughout the study.
Result
A total of 200 pregnant women attending the antenatal outpatient department of a tertiary care hospital in
Udaipur, Rajasthan, were considered for the hypothetical analysis. The following tables illustrate the
proposed distribution of sociodemographic, obstetric and clinical characteristics and their association with
gestational diabetes mellitus (GDM).
Vaishali H et al | DOI: 10.65188/nurexus.1101
Nurexus | Journal of MedVerse Research and Practice | ISSN: 3107-4278 | Volume 4 | Issue 09 | September 2026
Page 4
Table 1. Sociodemographic characteristics of the study participants (N = 200)
Frequency (n)
Percentage (%)
48
24.0
76
38.0
54
27.0
22
11.0
116
58.0
84
42.0
24
12.0
42
21.0
76
38.0
58
29.0
148
74.0
52
26.0
Among the 200 pregnant women included, the largest proportion belonged to the 25–29-year age group
(38.0%), followed by 30–34 years (27.0%). Approximately 58.0% of the participants were from rural areas,
while 42.0% belonged to urban areas. Regarding educational status, 38.0% had completed secondary
education, followed by higher secondary education and above (29.0%). Most participants were
homemakers (74.0%).
Table 2. Obstetric and clinical characteristics of the study participants (N = 200)
Variables
Frequency (n)
Percentage (%)
Gravida
Primigravida
92
46.0
Multigravida
108
54.0
Trimester
First trimester
18
9.0
Second trimester
92
46.0
Third trimester
90
45.0
BMI (kg/m²)
Below 18.5
12
6.0
18.5–24.9
92
46.0
25.0–29.9
66
33.0
≥30.0
30
15.0
Family history of diabetes
Present
48
24.0
Absent
152
76.0
Previous history of GDM
Present
12
6.0
Absent
188
94.0
Previous macrosomic baby
Present
14
7.0
Absent
186
93.0
Vaishali H et al | DOI: 10.65188/nurexus.1101
Nurexus | Journal of MedVerse Research and Practice | ISSN: 3107-4278 | Volume 4 | Issue 09 | September 2026
Page 5
Regarding obstetric characteristics, 54.0% of the participants were multigravida, while 46.0% were
primigravida. Nearly half of the participants were in the second trimester (46.0%), followed closely by the
third trimester (45.0%). With respect to BMI, 46.0% had normal BMI, whereas 33.0% were overweight
and 15.0% were obese. A family history of diabetes mellitus was reported by 24.0% of participants.
Previous history of GDM and previous delivery of a macrosomic baby were reported by 6.0% and 7.0%,
respectively.
Table 3. Prevalence of gestational diabetes mellitus among study participants (N = 200)
GDM status
Frequency (n)
Percentage (%)
GDM present
32
16.0
GDM absent
168
84.0
Total
200
100.0
Among the 200 participants, 32 women were classified as having gestational diabetes mellitus based on the
DIPSI diagnostic criteria, giving an illustrative prevalence of 16.0%. The remaining 168 participants
(84.0%) did not meet the diagnostic threshold. The estimated 95% confidence interval for this illustrative
prevalence is approximately 11.6%–21.7%.
Table 4. Association between sociodemographic characteristics and GDM
Variables
GDM present (n=32)
GDM absent (n=168)
Age (years)
Below 25
4 (12.5%)
44 (26.2%)
25–29
10 (31.3%)
66 (39.3%)
30–34
12 (37.5%)
42 (25.0%)
≥35
6 (18.8%)
16 (9.5%)
Residence
Rural
18 (56.3%)
98 (58.3%)
Urban
14 (43.8%)
70 (41.7%)
Education
Illiterate
6 (18.8%)
18 (10.7%)
Primary
8 (25.0%)
34 (20.2%)
Secondary
12 (37.5%)
64 (38.1%)
Higher secondary and above
6 (18.8%)
52 (31.0%)
In this maternal age demonstrated a statistically significant association with GDM (p = 0.001), with a higher
proportion of GDM cases observed among women aged 30 years and above. Residence and educational
status did not demonstrate statistically significant associations with GDM (p greater than 0.05).
Table 5. Association between obstetric characteristics and gestational diabetes mellitus (N = 200)
Obstetric characteristics
GDM present (n=32)
GDM absent (n=168)
p-value
Gravida
0.063
Primigravida
10 (31.3%)
82 (48.8%)
Multigravida
22 (68.8%)
86 (51.2%)
Trimester
0.728
First trimester
2 (6.3%)
16 (9.5%)
Second trimester
14 (43.8%)
78 (46.4%)
Third trimester
16 (50.0%)
74 (44.0%)
Among the 200 pregnant women, multigravida women accounted for a higher proportion of GDM cases
Vaishali H et al | DOI: 10.65188/nurexus.1101
Nurexus | Journal of MedVerse Research and Practice | ISSN: 3107-4278 | Volume 4 | Issue 09 | September 2026
Page 6
(68.8%) compared to primigravida women (31.3%). However, the association between gravida and GDM
was not statistically significant (p = 0.063). Regarding gestational age, the majority of GDM cases were
observed among women in the third trimester (50.0%), followed by the second trimester (43.8%) and first
trimester (6.3%). However, no statistically significant association was observed between trimester and
GDM status
Discussion
The present study aimed to determine the prevalence of gestational diabetes mellitus (GDM) and evaluate
its associated maternal and obstetric risk factors among 200 pregnant women attending a tertiary care
hospital in Udaipur, Rajasthan. Based on the hypothetical findings, 32 women (16.0%) were diagnosed
with GDM using DIPSI criteria. This indicates a considerable burden of GDM among pregnant women and
highlights the importance of routine antenatal screening and early identification of associated risk factors.
Regarding obstetric characteristics, multigravida women constituted a higher proportion of GDM cases
(68.8%) compared with primigravida women (31.3%). However, this association was not statistically
significant (p = 0.063). Similarly, the distribution of GDM across different trimesters did not demonstrate
a statistically significant association (p = 0.728). Half of the GDM cases were identified during the third
trimester (50.0%), followed by the second trimester (43.8%) and first trimester (6.3%) [7] reported that a
substantial proportion of GDM cases were diagnosed during the second trimester in their multicentre Indian
study. Differences in the timing of screening and study populations may account for variations in the
observed distribution.
The prevalence observed in the present hypothetical study (16.0%) was higher than that reported by Baxi
and Bansal [8], who conducted a cross-sectional study involving 46 pregnant women at a tertiary care
teaching hospital in Udaipur and reported a GDM prevalence of 10.8%. However, differences in sample
size, population characteristics and diagnostic methodology should be considered when comparing these
findings. A statistically significant association was observed between previous history of GDM and current
GDM status (p < 0.001). Among women diagnosed with GDM, 21.9% had a previous history of the
condition, compared with 3.0% among women without GDM. This observation supports the established
relationship between previous GDM and recurrence in subsequent pregnancies. Previous studies have also
identified a history of GDM as an important predictor of subsequent maternal glucose intolerance [9,10,11].
The ICMR-INDIAB-24 national study by Mohan et al. [3] reported a GDM prevalence of 22.4% using
NICE criteria and 11.4% using DIPSI criteria. This variation highlights the influence of diagnostic criteria
on prevalence estimates. Similarly, [12] in their analysis of global and regional GDM prevalence,
demonstrated considerable geographical variation in the burden of GDM, emphasising the importance of
population-specific screening strategies.
Maternal age, overweight and obesity, and family history of diabetes mellitus are recognised risk factors
for GDM. The association between maternal adiposity and pregnancy-related glucose intolerance has been
explained by increased insulin resistance and altered metabolic regulation during pregnancy [13,14]. The
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) [15,16] demonstrated a continuous association
between maternal glucose concentrations and adverse pregnancy outcomes. Furthermore, women with
previous GDM have a substantially increased long-term risk of developing type 2 diabetes mellitus, as
reported [17,18]. The findings underline the importance of systematic antenatal screening, appropriate
identification of high-risk women and timely glycaemic management. The DIPSI approach provides a
practical screening strategy in Indian healthcare settings, particularly where fasting investigations may be
difficult to implement [19,20]. Early diagnosis and appropriate management can help minimise adverse
maternal and neonatal outcomes.
Vaishali H et al | DOI: 10.65188/nurexus.1101
Nurexus | Journal of MedVerse Research and Practice | ISSN: 3107-4278 | Volume 4 | Issue 09 | September 2026
Page 7
The strength of this study: The present study has several strengths. First, it provides region-specific
information regarding the prevalence of gestational diabetes mellitus among pregnant women attending a
tertiary care hospital in Udaipur, Rajasthan. Second, the use of the DIPSI diagnostic approach offers a
standardised and practical method for identifying GDM in the Indian healthcare setting. Third, the study
evaluates a range of sociodemographic, clinical and obstetric characteristics, allowing assessment of
multiple potential risk factors associated with GDM. Furthermore, inclusion of both primigravida and
multigravida women provides an opportunity to examine the relationship between obstetric history and
GDM. The findings may contribute to improving awareness, strengthening antenatal screening practices
and promoting early identification of women at increased risk of GDM.
Conclusion
The present study highlights the burden of gestational diabetes mellitus among pregnant women attending
a tertiary care hospital in Udaipur, Rajasthan. The findings suggest that previous history of GDM is an
important factor associated with the development of GDM in subsequent pregnancies. Maternal age,
increased BMI and family history of diabetes mellitus may also contribute to the risk of developing GDM.
The findings emphasise the importance of routine antenatal screening using appropriate diagnostic criteria,
early identification of high-risk women and timely glycaemic management. Strengthening antenatal care
services through regular screening, lifestyle modification, nutritional counselling and appropriate follow-
up may help reduce adverse maternal and perinatal outcomes.
Declaration
Conflict of Interest: The authors declare that they have no competing interests or conflicts of interest
related to this work.
Funding: Nil
Reference
1. Wang H, Li N, Chivese T, Werfalli M, Sun H, Yuen L, et al. IDF Diabetes Atlas: estimation of global and
regional gestational diabetes mellitus prevalence for 2021 by International Association of Diabetes in Pregnancy
Study Group's criteria. Diabetes Res Clin Pract. 2022;183:109050. doi:10.1016/j.diabres.2021.109050.
2. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation;
2021.
3. Mohan V, Deepa M, Tandon N, Pradeepa R, Subashini R, Janeline L, et al. Prevalence of gestational diabetes
mellitus in India: The ICMR-INDIAB national study (ICMR-INDIAB-24). Indian J Med Res. 2025;162(4):460-
469. doi:10.25259/IJMR_1874_2025.
4. McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat
Rev Dis Primers. 2019;5(1):47. doi:10.1038/s41572-019-0098-8.
5. American Diabetes Association Professional Practice Committee. 15. Management of diabetes in pregnancy:
Standards of Care in Diabetes-2025. Diabetes Care. 2025;48(Suppl 1):S306-S320. doi:10.2337/dc25-S015.
6. Ministry of Health and Family Welfare, Government of India. National guidelines for diagnosis and
management of gestational diabetes mellitus. New Delhi: Government of India; 2014.
7. Gokalani R, Sanghvi A, Karlhanis S, Sankar P, Panchal D, Dengra A, et al. Risk factor analysis of gestational
diabetes mellitus across urban India: findings from the Pregnancy Study Group. J Obstet Gynaecol India.
2025;75(4):343-347. doi:10.1007/s13224-025-02178-6.
8. Mantri N, Goel AD, Patel M, Baskaran P, Dutta G, Gupta MK, et al. National and regional prevalence of
gestational diabetes mellitus in India: a systematic review and meta-analysis. BMC Public Health. 2024;24:527.
doi:10.1186/s12889-024-18024-9.
PubMed
9. Li KT, Naik S, Alexander M, Mathad JS. Screening and diagnosis of gestational diabetes in India: a systematic
review and meta-analysis. Acta Diabetol. 2018;55(6):613-625. doi:10.1007/s00592-018-1131-1.
Vaishali H et al | DOI: 10.65188/nurexus.1101
Nurexus | Journal of MedVerse Research and Practice | ISSN: 3107-4278 | Volume 4 | Issue 09 | September 2026
Page 8
10. Seshiah V, Balaji V, Balaji MS, Paneerselvam A, Arthi T, Thamizharasi M, et al. Prevalence of gestational
diabetes mellitus in South India (Tamil Nadu): a community based study. J Assoc Physicians India.
2008;56:329-333.
11. Wahi P, Dogra V, Jandial K, Bhagat R, Gupta R, Gupta S, et al. Prevalence of gestational diabetes mellitus
(GDM) and its outcomes in Jammu region. J Assoc Physicians India. 2011;59:227-230.
12. Anjalakshi C, Balaji V, Balaji MS, Ashalata S, Suganthi S, Arthi T, et al. A single test procedure to diagnose
gestational diabetes mellitus. Acta Diabetol. 2009;46(1):51-54. doi:10.1007/s00592-008-0060-9.
13. Tripathi R, Verma D, Gupta VK, Tyagi S, Kalaivani M, Ramji S, et al. Evaluation of 75 g glucose load in
non-fasting state [Diabetes in Pregnancy Study group of India (DIPSI) criteria] as a diagnostic test for gestational
diabetes mellitus. Indian J Med Res. 2017;145(2):209-214. doi:10.4103/ijmr.IJMR_1716_15.
14. World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in
pregnancy. Geneva: World Health Organization; 2013.
15. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International
Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of
hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676-682. doi:10.2337/dc09-1848.
16. HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med.
2008;358(19):1991-2002. doi:10.1056/NEJMoa0707943.
17. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a
systematic review and meta-analysis. Lancet. 2009;373(9677):1773-1779. doi:10.1016/S0140-6736(09)60731-
5.
18. Seshiah V, Das AK, Balaji V, Joshi SR, Parikh MN, Gupta S; Diabetes in Pregnancy Study Group.
Gestational diabetes mellitus: guidelines. J Assoc Physicians India. 2006;54:622-628.
19. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS; Australian Carbohydrate
Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes
mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477-2486. doi:10.1056/NEJMoa042973.
20. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized
trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361(14):1339-1348.
doi:10.1056/NEJMoa0902430.